Partnerships for Diabetes Related Disparties in Hawaii

夏威夷糖尿病相关政党的合作伙伴关系

基本信息

  • 批准号:
    6595678
  • 负责人:
  • 金额:
    $ 40.24万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2002
  • 资助国家:
    美国
  • 起止时间:
    2002-09-30 至 2007-09-29
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): MedStar Research Institute (MRI) is the partnering institution of the University of Hawaii on Project EXPORT. The overall purpose of our joint application is to address health disparities among Native Hawaiians (NHs) and Pacific Peoples (PP; including Pacific Islanders and Filipinos) in Hawaii. Among NHs, the indigenous people of Hawaii, high rates of obesity and diabetes compared to the U.S. national rates are well known. In accordance with these trends, rates of cardiovascular disease (CVD) among NHs have been on the rise while rates in the general U.S. population have been decreasing. Despite the considerable burden of chronic disease among NHs, there is relatively little published data on the health of this population and even less is known about other Pacific Peoples (PPs). The sparse literature available on NH health disparities contrasts with the fact that several research projects focused on this topic have been initiated over the last 15 years. Part of the reason for the relative lack of published data on NH health is due to the fact that the State of Hawaii does not have a coordinated effort or critical mass of researchers and research infrastructures to (1) make use of its existing data resources on NH health and PPs, (2) support the growth of new research activities on health disparities among NHs or PPs or (3) promote the professional development of new investigators and research professionals. As a partner to the University of Hawaii in Project EXPORT, MRI will have three roles: (1) Provide statistical and data management support; (2) design and implement the Molokai Native Hawaiian Heart Health Study and (3) design and implement culturally appropriate clinical training programs for investigators, allied health professionals and community members. This partnership is based on MRIs experience conducting clinical research in American Indians (AI) and Alaska Natives (AN), populations with strikingly similar health profiles as NHs and PPs (obesity, diabetes and CVD). A partnership between the University of Hawaii and MRI in promoting research in NH and PP health through Project EXPORT will (1) address key deficiencies in research infrastructures that currently exist in Hawaii, and (2) provide MRI with an opportunity to extend its research experience in AI and AN to similar studies in a NH population. The mutually beneficial nature of this partnership will ensure that the goals of this center grant are achieved. This partnership will also form the groundwork for future opportunities to examine common correlates of health disparities among native populations in the U.S. that share similar inequities in health status.
描述(由申请人提供):MedStar研究所(MRI)是夏威夷大学在出口项目上的合作机构。我们联合申请的总体目的是解决夏威夷土著夏威夷人(NH)和太平洋人民(PP;包括太平洋岛民和菲律宾人)之间的健康差距。在NHS中,夏威夷的土著居民,与美国全国比率相比,肥胖和糖尿病的高比率是众所周知的。根据这些趋势,NHS中心血管疾病(CVD)的发病率一直在上升,而美国普通人群的发病率一直在下降。尽管NHS的慢性病负担相当大,但关于这一人群健康的公开数据相对较少,对其他太平洋岛屿人(PP)的了解更少。关于NH健康差异的文献很少,这与过去15年来发起的几个专注于这一主题的研究项目形成了鲜明对比。相对缺乏关于NH健康的已发表数据的部分原因是,夏威夷州没有协调一致的努力或足够数量的研究人员和研究基础设施来(1)利用其现有的关于NH健康和PP的数据资源,(2)支持关于NHS或PP之间健康差异的新研究活动的增长,或(3)促进新研究人员和研究专业人员的专业发展。作为夏威夷大学出口项目的合作伙伴,MRI将发挥三个作用:(1)提供统计和数据管理支持;(2)设计和实施莫洛凯夏威夷土著人心脏健康研究;(3)为研究人员、专职医疗人员和社区成员设计和实施文化上适当的临床培训计划。这种伙伴关系是基于MRI在美洲印第安人(AI)和阿拉斯加原住民(AN)中进行临床研究的经验,这些人群的健康状况与NHS和PP(肥胖,糖尿病和CVD)惊人相似。夏威夷大学和MRI通过项目出口促进NH和PP健康研究的伙伴关系将(1)解决夏威夷目前存在的研究基础设施的关键缺陷,以及(2)为MRI提供一个机会,将其在AI和AN的研究经验扩展到NH人群的类似研究。这种伙伴关系的互利性质将确保该中心赠款的目标得以实现。这种伙伴关系还将为未来的机会奠定基础,以研究美国本土人口之间健康差异的共同相关性,这些人口在健康状况方面存在类似的不平等。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Barbara v Howard其他文献

Barbara v Howard的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Barbara v Howard', 18)}}的其他基金

CVD in American Indians Biomarker lab and Arizona Field Center
美洲印第安人生物标记实验室和亚利桑那现场中心的 CVD
  • 批准号:
    8368909
  • 财政年份:
    2013
  • 资助金额:
    $ 40.24万
  • 项目类别:
CVD in American Indians Biomarker lab and Arizona Field Center
美洲印第安人生物标记实验室和亚利桑那现场中心的 CVD
  • 批准号:
    8665465
  • 财政年份:
    2013
  • 资助金额:
    $ 40.24万
  • 项目类别:
Stop Atherosclerosis in Native Diabetics study (SANDS)
在本土糖尿病研究中阻止动脉粥样硬化 (SANDS)
  • 批准号:
    7123667
  • 财政年份:
    2002
  • 资助金额:
    $ 40.24万
  • 项目类别:
Stop Atherosclerosis in Native Diabetics study (SANDS)
在本土糖尿病研究中阻止动脉粥样硬化 (SANDS)
  • 批准号:
    6459919
  • 财政年份:
    2002
  • 资助金额:
    $ 40.24万
  • 项目类别:
Stop Atherosclerosis in Native Diabetics study (SANDS)
在本土糖尿病研究中阻止动脉粥样硬化 (SANDS)
  • 批准号:
    6953654
  • 财政年份:
    2002
  • 资助金额:
    $ 40.24万
  • 项目类别:
Partnerships for Diabetes Related Disparties in Hawaii
夏威夷糖尿病相关政党的合作伙伴关系
  • 批准号:
    7124302
  • 财政年份:
    2002
  • 资助金额:
    $ 40.24万
  • 项目类别:
Stop Atherosclerosis in Native Diabetics study (SANDS)
在本土糖尿病研究中阻止动脉粥样硬化 (SANDS)
  • 批准号:
    6667150
  • 财政年份:
    2002
  • 资助金额:
    $ 40.24万
  • 项目类别:
Stop Atherosclerosis in Native Diabetics study (SANDS)
在本土糖尿病研究中阻止动脉粥样硬化 (SANDS)
  • 批准号:
    7692504
  • 财政年份:
    2002
  • 资助金额:
    $ 40.24万
  • 项目类别:
Stop Atherosclerosis in Native Diabetics study (SANDS)
在本土糖尿病研究中阻止动脉粥样硬化 (SANDS)
  • 批准号:
    6801125
  • 财政年份:
    2002
  • 资助金额:
    $ 40.24万
  • 项目类别:
GENETICS OF CORONARY ARTERY DISEASE IN ALASKAN NATIVES
阿拉斯加原住民冠状动脉疾病的遗传学
  • 批准号:
    6796417
  • 财政年份:
    2000
  • 资助金额:
    $ 40.24万
  • 项目类别:

相似海外基金

FAIRClinical: FAIR-ification of Supplementary Data to Support Clinical Research
FAIRClinical:补充数据的 FAIR 化以支持临床研究
  • 批准号:
    EP/Y036395/1
  • 财政年份:
    2024
  • 资助金额:
    $ 40.24万
  • 项目类别:
    Research Grant
The IDeA State Consortium for a Clinical Research Resource Center: Increasing Clinical Trials in IDeA States through Communication of Opportunities, Effective Marketing, and WorkforceDevelopment
IDeA 州临床研究资源中心联盟:通过机会交流、有效营销和劳动力发展增加 IDeA 州的临床试验
  • 批准号:
    10715568
  • 财政年份:
    2023
  • 资助金额:
    $ 40.24万
  • 项目类别:
Optimizing integration of veterinary clinical research findings with human health systems to improve strategies for early detection and intervention
优化兽医临床研究结果与人类健康系统的整合,以改进早期检测和干预策略
  • 批准号:
    10764456
  • 财政年份:
    2023
  • 资助金额:
    $ 40.24万
  • 项目类别:
The Mayo Clinic NeuroNEXT Clinical Research Site
梅奥诊所 NeuroNEXT 临床研究网站
  • 批准号:
    10743328
  • 财政年份:
    2023
  • 资助金额:
    $ 40.24万
  • 项目类别:
Addressing Underperformance in Clinical Trial Enrollments: Development of a Clinical Trial Toolkit and Expansion of the Clinical Research Footprint
解决临床试验注册表现不佳的问题:开发临床试验工具包并扩大临床研究足迹
  • 批准号:
    10638813
  • 财政年份:
    2023
  • 资助金额:
    $ 40.24万
  • 项目类别:
The Minnesota TMD IMPACT Collaborative: Integrating Basic/Clinical Research Efforts and Training to Improve Clinical Care
明尼苏达州 TMD IMPACT 协作:整合基础/临床研究工作和培训以改善临床护理
  • 批准号:
    10828665
  • 财政年份:
    2023
  • 资助金额:
    $ 40.24万
  • 项目类别:
Improving Multicultural Engagement in Clinical Research through Partnership with Federally Qualified Health Centers and Community Health Worker Programs
通过与联邦合格的健康中心和社区卫生工作者计划合作,改善临床研究中的多元文化参与
  • 批准号:
    10823828
  • 财政年份:
    2023
  • 资助金额:
    $ 40.24万
  • 项目类别:
Promoting a Culture Of Innovation, Mentorship, Diversity and Opportunity in NCI Sponsored Clinical Research: NCI Research Specialist (Clinician Scientist) Award Application of Janice M. Mehnert, M.D.
在 NCI 资助的临床研究中促进创新、指导、多样性和机会文化:Janice M. Mehnert 医学博士的 NCI 研究专家(临床科学家)奖申请
  • 批准号:
    10721095
  • 财政年份:
    2023
  • 资助金额:
    $ 40.24万
  • 项目类别:
Clinical Research Center for REstoration of NEural-based Function in the Real World (RENEW)
现实世界神经功能恢复临床研究中心 (RENEW)
  • 批准号:
    10795328
  • 财政年份:
    2023
  • 资助金额:
    $ 40.24万
  • 项目类别:
Clinical Research and Academic Success in Obstetrics & Gynecology
产科临床研究和学术成就
  • 批准号:
    10828252
  • 财政年份:
    2023
  • 资助金额:
    $ 40.24万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了